Deep Diving into the Cost Effectiveness of Anti-Obesity and Type 2 Diabetes Therapeutics to Encourage Wider Coverage
Time: 2:00 pm
day: Conference Day Two
Details:
- Debunking the big price tags carried by AOMs and by highlighting the discrepancy between initial estimates and actual costs
- Understanding the role of pharmaceutical company sponsorships and pharmacy benefit manager discounts in mitigating costs and making AOMs a realistic price for patients
- Emphasizing the importance of accurate cost modelling and population analysis to understand the true effects that providing AOM coverage will have on budgets
